Correlates of insulin resistance in older individuals with and without kidney disease.
BACKGROUND
Chronic kidney disease (CKD) is associated with insulin resistance (IR). Prior studies have found that in individuals with CKD, leptin is associated with fat mass but resistin is not and the associations with adiponectin are conflicting. This suggests that the mechanism and factors associated with IR in CKD may differ.


METHODS
Of the 2418 individuals without reported diabetes at baseline, participating in the Health, Aging and Body Composition study, a study in older individuals aged 70-79 years, 15.6% had CKD defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m(2) based on cystatin C. IR was defined as the upper quartile of the homeostasis model assessment. The association of visceral and subcutaneous abdominal fat, percent body fat, muscle fat, lipids, inflammatory markers and adiponectin were tested with logistic regression. Interactions were checked to assess whether the factors associated with IR were different in those with and without CKD.


RESULTS
Individuals with IR had a lower eGFR (80.7 ± 20.9 versus 75.6 ± 19.6, P < 0.001). After multivariable adjustment, eGFR (odds ratio per 10 mL/min/1.73 m(2) 0.92, 95% confidence interval 0.87-0.98) and CKD (1.41, 1.04-1.92) remained independently associated with IR. In individuals with and without CKD, the significant predictors of IR were male sex, black race, higher visceral fat, abdominal subcutaneous fat and triglycerides. In individuals without CKD, IR was associated with lower high-density lipoprotein and current nonsmoking status in multivariate analysis. In contrast, among individuals with CKD, interleukin-6 (IL-6) was independently associated with IR. There was a significant interaction of eGFR with race and IL-6 with a trend for adionectin but no significant interactions with CKD (P > 0.1). In the fully adjusted model, there was a trend for an interaction with adiponectin for eGFR (P = 0.08) and significant for CKD (P = 0.04 ), where adiponectin was associated with IR in those without CKD but not in those with CKD.


CONCLUSIONS
In mainly Stage 3 CKD, kidney function is associated with IR; except for adiponectin, the correlates of IR are similar in those with and without CKD.
Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Michael
M
Landau
Manjula
M
Kurella-Tamura
Michael G
MG
Shlipak
Alka
A
Kanaya
Elsa
E
Strotmeyer
Annemarie
A
Koster
Suzanne
S
Satterfield
Eleanor M
EM
Simsonick
Bret
B
Goodpaster
Anne B
AB
Newman
Linda F
LF
Fried
D052242:Adiponectin / Q000378:metabolism; D000368:Aged; D015415:Biomarkers / Q000378:metabolism; D015992:Body Mass Index; D055316:Cystatin C / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006801:Humans; D007333:Insulin Resistance; D015850:Interleukin-6 / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000150:complications*; D007677:Kidney Function Tests; D008075:Lipoproteins, HDL / Q000378:metabolism; D008297:Male; D011379:Prognosis; D052243:Resistin / Q000378:metabolism; D015996:Survival Rate
D052242:Adiponectin; D015415:Biomarkers; D055316:Cystatin C; D015850:Interleukin-6; D008075:Lipoproteins, HDL; D052243:Resistin
Eur Heart J. 2008 Dec;29(24):2959-71
18775919
J Clin Invest. 1981 Feb;67(2):563-8
7007440
J Am Soc Nephrol. 2005 Apr;16(4):1091-8
15743998
Metabolism. 2005 Mar;54(3):330-4
15736110
Endocr Res. 1985;11(1-2):113-25
3899621
Kidney Int. 1998 May;53(5):1343-7
9573550
Am J Kidney Dis. 2005 Feb;45(2):275-80
15685504
Am J Kidney Dis. 2008 Mar;51(3):395-406
18295055
Kidney Int. 2006 Feb;69(3):596-604
16395259
Kidney Int. 2004 Mar;65(3):881-7
14871407
Curr Opin Nephrol Hypertens. 2008 Jan;17(1):25-31
18090666
Ren Fail. 2007;29(2):147-54
17365928
Nephrology (Carlton). 2008 Dec;13(6):528-34
19138207
J Clin Endocrinol Metab. 2002 Nov;87(11):5044-51
12414870
J Am Geriatr Soc. 2007 Oct;55(10):1578-84
17908060
Kidney Int. 2004 Jan;65(1):274-81
14675060
Diabetes. 2003 Oct;52(10):2490-6
14514631
Diabetes. 2003 Jul;52(7):1779-85
12829646
Kidney Int. 2006 Aug;70(3):453-9
16871256
J Clin Endocrinol Metab. 2001 Nov;86(11):5457-64
11701722
J Clin Invest. 1995 Jul;96(1):88-98
7615840
J Am Soc Nephrol. 2005 Jul;16(7):2134-40
15901764
Nephron. 2001 Nov;89(3):348-9
11598402
Kidney Int. 1996 Dec;50(6):1928-35
8943476
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S13-8
19136982
J Appl Physiol (1985). 2003 Jun;94(6):2368-74
12598481
Diabetes. 1993 Feb;42(2):273-81
8425663
Diabetes. 2008 May;57(5):1269-75
18299316
Am J Kidney Dis. 2009 Jan;53(1):59-69
18838200
Clin Nephrol. 2000 Nov;54(5):366-73
11105797
Am J Clin Nutr. 1980 Jul;33(7):1438-45
6994471
Diabetes. 1997 Oct;46(10):1579-85
9313753
Ann Intern Med. 2009 May 5;150(9):604-12
19414839
J Am Soc Nephrol. 2003 Feb;14(2):469-77
12538749
Nephrol Dial Transplant. 2008 Oct;23(10):3041-6
18632589
Nephron. 1995;69(3):281-5
7753261
J Clin Invest. 1983 Jun;71(6):1581-7
6345585
Am J Clin Nutr. 2004 Nov;80(5):1222-9
15531669
Circulation. 2005 Oct 25;112(17):2735-52
16157765
Intern Med. 2010;49(4):299-305
20154435
Hypertension. 1996 Jul;28(1):127-32
8675252
Diabetes Care. 2008 Aug;31(8):1550-5
18509205
J Ren Nutr. 2009 May;19(3):197-203
19393918
Kidney Int. 2009 Apr;75(7):711-8
19177156
Diabetologia. 1995 May;38(5):565-72
7489839